Advertisement

Table of Contents

April 01, 1988; Volume 33,Issue 4

You have access
A novel high affinity class of Ca2+ channel blockers.
J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski

Molecular Pharmacology April 1988, 33 (4) 363-369;
You have access
Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.
K Thermos and T Reisine

Molecular Pharmacology April 1988, 33 (4) 370-377;
You have access
Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequences.
M E Goldsmith and K H Cowan

Molecular Pharmacology April 1988, 33 (4) 378-383;
You have access
Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
G Yu, S Grant and R I Glazer

Molecular Pharmacology April 1988, 33 (4) 384-388;
You have access
Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts

Molecular Pharmacology April 1988, 33 (4) 389-395;
You have access
Role of epoxide in neocarzinostatin chromophore stability and action.
S H Lee and I H Goldberg

Molecular Pharmacology April 1988, 33 (4) 396-401;
You have access
Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar

Molecular Pharmacology April 1988, 33 (4) 402-413;
You have access
Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
S K Fisher

Molecular Pharmacology April 1988, 33 (4) 414-422;
You have access
Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
L L Werling, P S Puttfarcken and B M Cox

Molecular Pharmacology April 1988, 33 (4) 423-431;
You have access
Covalent labeling of vasopressin receptors from LLC-PK1 cells by the use of a bifunctional reagent.
J Marie and C Roy

Molecular Pharmacology April 1988, 33 (4) 432-440;
You have access
The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
W J Parsons, V Ramkumar and G L Stiles

Molecular Pharmacology April 1988, 33 (4) 441-448;
You have access
Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon

Molecular Pharmacology April 1988, 33 (4) 449-453;
You have access
Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
J M Zamora, H L Pearce and W T Beck

Molecular Pharmacology April 1988, 33 (4) 454-462;
You have access
Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria.
F De Matteis

Molecular Pharmacology April 1988, 33 (4) 463-469;
You have access
Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
I Debing, A P Ijzerman and G Vauquelin

Molecular Pharmacology April 1988, 33 (4) 470-476;
You have access
Sulfation of benzylic alcohols catalyzed by aryl sulfotransferase IV.
T P Binder and M W Duffel

Molecular Pharmacology April 1988, 33 (4) 477-479;